Clinical Trial Update: EF5 in Melanoma Patients [Phase 1]

View source ↗

Summary

Phase 1 trial of EF5 in melanoma patients has completed. This document provides an update on the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• EF5

Snippet

Sponsor: Douglas Tyler | Conditions: Melanoma | Phase 1 | Status: COMPLETED